The [1-13C]Lactate/[1-13C]Bicarbonate ratio at 48 hrs post-treatment, as measured in a hyperpolarized [1-13C]Pyruvate experiment, was found to accurately predict the survival in rat C6 glioma model treated with a single dose of the anti-VEGF drug Bevacizumab.
This abstract and the presentation materials are available to members only; a login is required.